Scholarly Index
Giulio Cavalli
Novartis (Switzerland); 8,511 total citations; 183 total publications; best world rank #147
Novartis (Switzerland)
8,511Total citations
183Total publications
44H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 Clinical Research Studies | Lifetime | 909 | CH 11 | 97.01 |
| Inflammasome and immune disorders | Lifetime | 592 | CH 13 | 95.09 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 725 | CH 10 | 95.74 |
| Histiocytic Disorders and Treatments | Lifetime | 213 | CH 4 | 94.73 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 308 | CH 4 | 92.10 |
| Whipple's Disease and Interleukins | Lifetime | 474 | CH 12 | 67.72 |
| Inflammasome and immune disorders | 2021-2025 | 147 | CH 2 | 94.07 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 624 | CH 8 | 87.87 |
| Histiocytic Disorders and Treatments | 2021-2025 | 359 | CH 2 | 59.11 |